23 June 2020
Chemicals compliance
The ECHA Member State Committee has not accepted to identify resorcinol as an SVHC substance due to its endocrine disrupting properties.
The Member State Committee has not unanimously supported France's proposal to identify resorcinol (EC 203-585-2; CAS 108-46-3) as SVHC. However, the committee acknowledged the existence of scientific evidence that resorcinol is an endocrine disruptor as defined by the World Health Organization (WHO).
After receiving the MSC's opinion, the Commission has three months to prepare a draft proposal on identification as SVHC and will therefore take a final decision in its committee procedure.
Resorcinol is used to produce rubber compounds, resins and coatings, as well as cosmetics. It is the first substance proposed as SVHC because of its harmful effects on the thyroid in humans. The majority of the committee members concluded that there is scientific evidence of likely serious effects on human health due to hypothyroidism and potential effects on neurological development during pregnancy. However, some members expressed different opinions that the substance presents an equivalent level of concern.
For more information visit the ECHA website.
04 April 2024
Chemicals compliance
On 3 April 2024, Regulation 2024/996 amending Annexes II, III, V and VI of Regulation (EC) No 1223/2009 was published. Below is the list of the amendments: Annex II (prohibited substances): the substance...